Ulk1 — Ulk1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ULK1 Protein | |
|---|---|
| Protein Name | ULK1 Protein |
| Gene | ULK1 |
| UniProt ID | Q9P2R7 |
| PDB IDs | 5W5V, 4WNO |
| Molecular Weight | 105 kDa |
| Subcellular Localization | Cytoplasm, Autophagosome |
| Protein Family | Ser/Thr kinase, ULK family |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis |
ULK1 (Unc-51 Like Kinase 1) is a protein encoded by a gene located on chromosome 12p24.11. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. ULK1 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
ULK1 contains an N-terminal serine/threonine kinase domain, followed by a proline-rich region, and a C-terminal domain that mediates interactions with ATG13 and FIP200. The kinase domain adopts a typical kinase fold with the activation loop containing critical regulatory phosphorylation sites (Ser317, Ser555, Ser637, Ser777). Recent crystal structures reveal the molecular basis for AMPK recognition and activation. Post-translational modifications including phosphorylation, ubiquitination, and SUMOylation regulate ULK1 activity and stability.
ULK1 (UNC-51 Like Kinase 1) is a serine/threonine-protein kinase that plays a central role in the initiation of autophagy. The ULK1 complex consists of ULK1, ATG13, FIP200 (RB1CC1), and ATG101, which localizes to the phagophore assembly site to initiate autophagosome formation. ULK1 is directly phosphorylated by AMPK at multiple sites in response to cellular energy stress (low ATP/AMP ratio), linking nutrient sensing to autophagy. ULK1 also phosphorylates numerous autophagy-related proteins including Beclin 1, ATG14, and p62/SQSTM1 to promote autophagy progression. In neurons, ULK1-mediated mitophagy is critical for mitochondrial quality control, and dysfunction contributes to neurodegenerative diseases characterized by protein aggregate accumulation and mitochondrial dysfunction.
Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis are associated with dysregulation of ULK1. Altered expression or function contributes to disease pathogenesis through various mechanisms including impaired protein homeostasis, calcium dysregulation, and synaptic dysfunction.
Therapeutic targeting of ULK1 for neurodegeneration:
The study of Ulk1 — Ulk1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.